Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MBIO

MindBio Therapeutics (MBIO)

MindBio Therapeutics Corp
Date:
Sort by:
 Showing the most relevant articles for your search:CSE:MBIO
DateTimeSourceHeadlineSymbolCompany
08/24/20239:00AMInvestorsHub NewsWireMindbio Therapeutics Begins Dosing MB22001 In Phase 2 Clinical Trial In World First Take-home Microdosing Study In Patients With DepressionCSE:MBIOMindBio Therapeutics Corp
06/14/20238:00AMInvestorsHub NewsWireMindBio Therapeutics Breakthrough Discovery in Microdosing Clinical Trial Reveals Significant Positive Effects on Quality Of SleepCSE:MBIOMindBio Therapeutics Corp
05/30/20238:00AMInvestorsHub NewsWireMindBio Therapeutics CEO Demonstrates how 1 Million Microdoses of LSD can Potentially be Used to Treat Depression at ScaleCSE:MBIOMindBio Therapeutics Corp
05/23/20238:15AMInvestorsHub NewsWireMindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive DisorderCSE:MBIOMindBio Therapeutics Corp
05/11/20238:29AMInvestorsHub NewsWireMindBio Therapeutics Phase 2 Clinical Trial Has Received Ethics Approval for World First Take-Home LSD-Microdosing Trials in Cancer Patients Experiencing Emotional DistressCSE:MBIOMindBio Therapeutics Corp
05/09/20239:13AMInvestorsHub NewsWireMindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy ParticipantsCSE:MBIOMindBio Therapeutics Corp
 Showing the most relevant articles for your search:CSE:MBIO